ArticleJournal of hepatocellular carcinoma2023

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study.

Chenghao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.